VINCERE VITAE
Compound Intelligence
MOTS-C
Latest research activity, publications, abstracts, and scientific signals for MOTS-C.
Total Papers
9
Primary Source
PubMed
Status
Tracking
Intelligence Summary
MOTS-C currently has 9 tracked PubMed research entries in Research Radar. The latest tracked publication is "MOTS-c attenuates hyperoxia-induced neonatal cardiac injury by inhibiting oxeiptosis via maintaining the KEAP1-PGAM5 interaction.".
Journals
9
Authors
80
Latest Publication
2026 Aug 1
Trend Score
100
Research Activity
Research activity detected through PubMed ingestion.
Source Quality
Current intelligence is based on PubMed metadata and abstracts only.
Status
Tracking
Research Velocity
Measures recent publication momentum for MOTS-C.
Last 30 Days
6
Last 90 Days
8
Trend Direction
Increasing
Latest MOTS-C Research
PubMed
MOTS-c attenuates hyperoxia-induced neonatal cardiac injury by inhibiting oxeiptosis via maintaining the KEAP1-PGAM5 interaction.
Life sciences · 2026 Aug 1
PubMed
MOTS-c: How a secreted mitochondrial microprotein may become a potential treatment for inflammatory lung diseases.
Journal of translational medicine · 2026 Jun 4
PubMed
MOTS-c preserves mitochondrial subpopulation bioenergetics and genome integrity to attenuate cardiac ischemia reperfusion injury.
Molecular biology reports · 2026 Jun 2
PubMed
MOTS-c, a mitochondrial-derived peptide, ameliorates lysosomal membrane permeability and improves survival of soft tissue transplantation.
Autophagy · 2026 Jun 2
PubMed
Elevated Serum Nardilysin Is Inversely Associated with Cardiovascular Disease in Kidney Transplant Recipients.
Kidney & blood pressure research · 2026 May 21
PubMed
MOTS-c is associated with oxidative stress and arterial stiffness in peritoneal dialysis patients: a pilot study.
International urology and nephrology · 2026 May 13
PubMed
LAT1-mediated delivery of engineered R13A-MOTS-c attenuates radiation-induced lung injury via Nrf2 activation and mitochondrial protection.
Redox biology · 2026 May 9
PubMed
Humanin and MOTS-c Attenuate Atrial Fibrillation by Suppressing Fibrosis and Mitochondrial Dysfunction.
Unknown journal · 2026 05 05
PubMed
MOTS-c partially protects against skeletal muscle deterioration in C26 cachexia.
Frontiers in medicine · 2026